Pomalidomide-PEG4-CH2COOH CAS:2097938-44-6 is a chemical compound that consists of three functional groups: Pomalidomide, PEG4, and CH2COOH.
Pomalidomide is a potent immunomodulatory drug that has been approved by the FDA for the treatment of multiple myeloma. It works by activating the immune system to attack cancer cells and by inhibiting the growth of new blood vessels that tumors need to survive.
PEG4, or polyethylene glycol 4, is a hydrophilic polymer that is commonly used as a linker molecule in drug development. It can improve the solubility and bioavailability of drugs, as well as reduce their immunogenicity and toxicity.
CH2COOH, or carboxylic acid, is a versatile functional group that can be used for conjugation with other molecules or for modification of the physical and chemical properties of drugs. It can also act as a linker molecule in drug development.
The combination of Pomalidomide, PEG4, and CH2COOH in Pomalidomide-PEG4-CH2COOH represents a novel approach to drug development, allowing for improved drug solubility, bioavailability, and targeted delivery to cancer cells. This compound may have potential applications in the treatment of multiple myeloma and other types of cancer.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
